Individualized Antithrombotic Therapy for Patients With Ischemic Cerebrovascular Disease
NCT03471169
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
3500
Enrollment
OTHER
Sponsor class
Conditions
Cerebrovascular Disease
Interventions
DRUG:
Desirable TEG
DRUG:
Undesirable TEG
Sponsor
Xuanwu Hospital, Beijing
Collaborators
[object Object]
[object Object]